trial · primary record
LP-118
Philadelphia Positive Acute Lymphoblastic Leukemia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 26 |
| Primary completion | 2030-03 |
| Primary endpoint | Estimation of the Maximum Tolerated Dose (MTD) for LP-118 (Dose Escalation) |
| Registry ID | NCT07614022 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:36.986Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07614022
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.